HIV Clinical Trials is devoted exclusively to keeping you in touch with the latest developments and techniques in HIV/AIDS therapeutics. This is where you'll gain a more complete picture of worldwide developments.
HIV Clinical Trials coverage includes:
-
the results of therapeutic, diagnostic, or preventive clinical trials, reports of clinical research, and meta-analyses
- pilot studies
- methodological papers
-
review articles
-
quality of life and pharmacoeconomic evaluations
-
controversies
-
invited editorial comments
-
book reviews
-
letters to the editor
-
abstracts of conferences
Subscriptions include online access to the current issue and a full-text archive of all previous issues
Search the current issue, or across hundreds of articles from previous issues. Onlne access to HIV Clinical Trials is easy, comprehensive, and doesn't involve any additional charges for subscribers.
Build your knowledge base with authoritative, practical information
Editor-in-Chief, Milos Opravil, MD, of the University Hospital Zurich, works closely with a world-renowned Board of Editors from 16 countries to ensure that HIV Clinical Trials delivers the insightful information on HIV/AIDS therapeutics you need.
HIV Clinical Trials is indexed in Index Medicus and MEDLINE; EMBASE, the Excerpta Medica database and Elsevier BIOBASE; Science Index® Expanded®, ISI Alerting Services® and Current Contents®/Clinical Medicine®.
Thinking of writing for HIV Clinical Trials?
Our current Impact Factor in Journal Citation Reports® is 1.704. We combine a thorough peer review process with faster time to publication; typically about 4 months from receipt of a manuscript to publication.
HIV Clinical Trials also publishes "Brief Reports" in an average of 8 weeks from receipt of your manuscript.
Our commitment is to get your information to the field at the earliest date that can be responsibly achieved. For more information on writing for HIV Clinical Trials see our instructions for authors.
Click here to submit your manuscript online.
NEW
HIV Clinical Trials now awards 6 months of online access for on-time peer review
Each time peer review is completed by the requested date, your online access is extended 6 months from that date. You will have full online access to all articles from the current issue to the first issue. To become a peer reivewer register on our online manuscript submission system.
Subscribe now
To subscribe, or for more information on rates, click the SUBSCRIBE NOW link below. In the U.S. and Canada you may call 1-800-633-4931. Outside the U.S. and Canada call +205-995-1567.
›SUBSCRIBE NOW
›Online Access
›Back Issues in Print
›Editorial Board
›Instructions for Authors
›Submit your manuscript online
›Information for Advertisers |
Home
